CHINAAMC Hang Seng Biotech ETF (HKG:3069)
Hong Kong · Delayed Price · Currency is HKD 16.62
+0.01 (0.06%)
Last updated: Sep 22, 2026, 3:59 PM HKT
HKG:3069 Holdings Information
HKG:3069 is an equity ETF with a total of 10 individual holdings. The top holdings are Innovent Biologics stock at 10.03%, BeOne Medicines AG at 10.03%, WuXi Biologics at 9.78%, WuXi AppTec at 8.31%, and Akeso at 7.23%.
Total Holdings
10
Top 10 Percentage
68.76%
Asset Class
Equity
ETF Category
Health Care
Assets
2.47B
PE Ratio
22.03
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | HKG: 1801 | Innovent Biologics, Inc. | 10.03% |
| 2 | HKG: 6160 | BeOne Medicines AG | 10.03% |
| 3 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 9.78% |
| 4 | HKG: 2359 | WuXi AppTec Co., Ltd. | 8.31% |
| 5 | HKG: 9926 | Akeso, Inc. | 7.23% |
| 6 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 6.27% |
| 7 | HKG: 1177 | Sino Biopharmaceutical Limited | 5.07% |
| 8 | HKG: 3692 | Hansoh Pharmaceutical Group Company Limited | 5.00% |
| 9 | HKG: 1530 | 3SBio Inc. | 3.82% |
| 10 | C.0 02.18.27 000A | Citigroup Global Markets Holdings Inc. | 3.21% |
As of Jun 30, 2026